AngioDynamics, Inc. (NASDAQ:ANGO) Shares Bought by Ameriprise Financial Inc.

Ameriprise Financial Inc. raised its stake in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 24.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 277,565 shares of the medical instruments supplier's stock after purchasing an additional 53,675 shares during the period. Ameriprise Financial Inc. owned 0.69% of AngioDynamics worth $2,542,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Segall Bryant & Hamill LLC boosted its holdings in AngioDynamics by 55.3% in the fourth quarter. Segall Bryant & Hamill LLC now owns 1,415,156 shares of the medical instruments supplier's stock worth $12,963,000 after acquiring an additional 503,713 shares in the last quarter. Marshall Wace LLP boosted its holdings in AngioDynamics by 1,335.1% in the fourth quarter. Marshall Wace LLP now owns 476,824 shares of the medical instruments supplier's stock worth $4,368,000 after acquiring an additional 443,598 shares in the last quarter. Arrowstreet Capital Limited Partnership boosted its holdings in AngioDynamics by 293.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 352,544 shares of the medical instruments supplier's stock worth $3,229,000 after acquiring an additional 263,034 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in AngioDynamics by 46.0% in the fourth quarter. JPMorgan Chase & Co. now owns 807,483 shares of the medical instruments supplier's stock worth $7,397,000 after acquiring an additional 254,322 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. boosted its holdings in AngioDynamics by 69.0% in the fourth quarter. Connor Clark & Lunn Investment Management Ltd. now owns 389,053 shares of the medical instruments supplier's stock worth $3,564,000 after acquiring an additional 158,897 shares in the last quarter. Hedge funds and other institutional investors own 89.43% of the company's stock.

AngioDynamics Stock Down 4.9%

Shares of AngioDynamics stock traded down $0.50 on Monday, reaching $9.70. 1,137,231 shares of the stock were exchanged, compared to its average volume of 563,615. AngioDynamics, Inc. has a twelve month low of $5.47 and a twelve month high of $13.50. The firm has a market capitalization of $393.89 million, a price-to-earnings ratio of -1.72 and a beta of 0.58. The business has a 50 day moving average price of $9.47 and a two-hundred day moving average price of $9.61.

AngioDynamics (NASDAQ:ANGO - Get Free Report) last released its earnings results on Wednesday, April 2nd. The medical instruments supplier reported $0.03 EPS for the quarter, topping analysts' consensus estimates of ($0.13) by $0.16. AngioDynamics had a negative return on equity of 7.26% and a negative net margin of 79.38%. The firm had revenue of $72.00 million during the quarter, compared to the consensus estimate of $70.30 million. The company's revenue for the quarter was down 4.3% compared to the same quarter last year. Research analysts forecast that AngioDynamics, Inc. will post -0.37 EPS for the current year.

Wall Street Analyst Weigh In

Separately, HC Wainwright reissued a "buy" rating and issued a $16.00 price target (up previously from $15.00) on shares of AngioDynamics in a report on Monday, April 7th.

AngioDynamics Company Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.